Blood Tests, Microneedle Patches and Protein Markers Advance Non-Invasive Disease Monitoring
Sourced from 6 publications
- •A microneedle patch the size of a quarter samples immune cells often missed in traditional blood draws and biopsies, according to BH Pioneer.
- •Plasma microbial cell-free DNA sequencing detected bloodstream infection pathogens in children with high-risk leukemia days before standard diagnosis, per Medical Xpress.
- •Researchers at the MPI of Biochemistry and TU Munich identified new protein-based diagnostic markers for multiple sclerosis in cerebrospinal fluid.
- •Technology Networks reported a blood test that can track gene activity in the brain, though detailed methodology was not publicly available.
- •All reported findings are at early research stages without confirmed timelines for clinical implementation.
Sources
A new method reveals hidden rules of gene control | Newswise - Newswise
A Blood Test That Can Track Gene Activity in the Brain - Technology Networks
‘Painless’ patch provides more accurate way to monitor immune conditions
bhpioneer
Nanoparticles, AI Help Researchers Detect Pollutants in Water, Soil and Blood -...
Researchers teach 'biological computer' made from human brain cells to play Doom
News
Cell-free DNA offers early warning for bloodstream infections in kids with leuke...
Medicalxpress
New Device Detects Brain Waves in Mini Brains Mimicking Early Human Development
Singularityhub
Growth hormone receptor could serve as possible target for improving lung cancer...
Medicalxpress
New diagnostic markers for multiple sclerosis discovered in cerebrospinal fluid
Medicalxpress
Research roundup: Six cool science stories we almost missed
Ars Technica
Curated from 6 sources. Every summary is reviewed for accuracy, but may still contain errors. We always link to original sources for verification.
Related Stories
About Meridian
Meridian is a free daily newsletter delivering signal-scored news stories with forward-looking analysis every morning. Stories are scored across six criteria (global leverage, capital impact, temporal durability, career relevance, decision utility, and narrative clarity) then assigned to Big Signal, Core, or Quick tiers.
Get Meridian in your inbox
The stories that matter, every morning at 06:00.